Arginase inhibition to modulate the TME: Rationale and early clinical experience

Date 15 December 2018
Event ESMO Immuno-Oncology Congress 2018
Session Immuno-oncology: State of the art I
Topics Translational Research
Therapy
Presenter Sonia Ioannidis
Authors S. Ioannidis
  • Incyte Biosciences International Switzerland, 1066 - Epalinges/CH